Back to top

Is CRVS poised for gains? 200 Day Moving Average Support shows up after gaining 1.15%

Corvus Pharmaceuticals, Inc. (CRVS) โ€” Nightly Technical Analysis ยท Jul 30, 2026, 19:56 ET
CRVS finished higher by 1.15% on Thursday, July 30th, trading 0.7 times its typical volume. Mixed technical signals appeared with 200 DMA Support suggesting upside potential, while 50 DMA Resistance indicated possible weakness โ€” creating a conflicted technical picture. Key support levels exist at 12.96, 12.73 & 12.55, with resistance at 13.37, 13.56 & 13.79. Meanwhile, Slow Stochastic is showing oversold conditions.

Current SwingTradeBot Technical Rating of CRVS: C

Just a sneak peek โ€” check SwingTradeBot.com for the full story on CRVS.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Corvus Pharmaceuticals, Inc. (CRVS)